Antitumor agent-180
Product Specifications
Target
Apoptosis
Related Pathways
Apoptosis
Bioactivity
Antitumor agent-180 (Compound 13a) is an inhibitor of BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) . It suppresses the proliferation of ccRCC cells Caki-1 with an IC50 of 2.047 µM and induces necrosis and apoptosis in Caki-1 cells.
Molecular Formula
C34H41N9O
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15206773 1 Vial
Lentiviral mouse Svil shRNA (UAS) - Lentiviral mouse Svil shRNA (UAS, RFP) plasmid
Ask
View Details abx521790 96 Tests
Rat Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) ELISA Kit
Ask
View Details